Susanne Haas Selected Research

Susanne Haas Research Topics

Disease

13	Breast Neoplasms (Breast Cancer) 09/2013 - 05/2005
11	Neoplasms (Cancer) 12/2021 - 10/2006
3	Anus Neoplasms (Anal Cancer) 12/2021 - 01/2018
2	Rectal Neoplasms (Rectal Cancer) 09/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 03/2008 - 10/2005
1	Gastroesophageal Reflux (GERD) 12/2012
1	Carcinogenesis 12/2010
1	Adenoma (Adenomas) 06/2009
1	Pleomorphic Adenoma 06/2009
1	Sialadenitis 06/2009
1	Fibrosis (Cirrhosis) 01/2009
1	Type 2 Diabetes Mellitus (MODY) 01/2009
1	Focal Nodular Hyperplasia 01/2009
1	Inflammation (Inflammations) 03/2008
1	Colorectal Neoplasms (Colorectal Cancer) 12/2007
1	Lymphatic Metastasis 10/2006
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 02/2006
1	Papillomavirus Infections 11/2005
1	Carcinoid Tumor (Carcinoid) 10/2005
1	Hemochromatosis (Bronze Diabetes) 05/2005
1	Autoimmune Hepatitis 05/2005
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2005
1	Acidosis 10/2003

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 12/2010 - 10/2006
4	Estrogen ReceptorsIBA 09/2013 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 12/2010 - 10/2006
3	Cytochrome P-450 CYP3AIBA 12/2010 - 10/2006
3	SteroidsIBA 12/2010 - 10/2006
3	Hormones (Hormone)IBA 12/2010 - 10/2006
2	Estrogen Receptor alphaIBA 03/2010 - 09/2008
2	XenobioticsIBA 01/2009 - 10/2006
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2009 - 10/2006
2	glutathione S-transferase alphaIBA 01/2009 - 10/2006
1	Proton Pump InhibitorsIBA 12/2012
1	Coffee FDA Link 03/2010
1	TeaIBA 03/2010
1	AcetyltransferasesIBA 03/2010
1	Complex MixturesIBA 03/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2010
1	AminesIBA 03/2010
1	trichostatin A (A 300)IBA 08/2009
1	Antimicrobial PeptidesIBA 06/2009
1	Messenger RNA (mRNA)IBA 06/2009
1	beta-DefensinsIBA 06/2009
1	human ERBB2 proteinIBA 05/2009
1	histidine-rich proteinsIBA 02/2009
1	Trastuzumab (Herceptin)FDA Link 02/2009
1	Neuregulin-1 (Neuregulin 1)IBA 02/2009
1	LigandsIBA 02/2009
1	TransferasesIBA 01/2009
1	Glutathione (Reduced Glutathione)IBA 01/2009
1	Mitogen-Activated Protein Kinase 3IBA 04/2008
1	lymphocyte-specific protein p50IBA 04/2008
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2008
1	Plasminogen Activator Inhibitor 1IBA 03/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2008
1	ParaffinIBA 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 12/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2007
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 06/2007
1	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2006
1	CarcinogensIBA 10/2006
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 10/2006
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 10/2006
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 10/2006
1	Protein Isoforms (Isoforms)IBA 10/2006
1	AntibodiesIBA 02/2006
1	antiglomerular basement membrane antibodyIBA 02/2006
1	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2005
1	AutoantigensIBA 05/2005
1	Transferrin Receptors (Transferrin Receptor)IBA 05/2005
1	IronIBA 05/2005
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2003
1	Dialysis SolutionsIBA 10/2003
1	Bicarbonates (Hydrogen Carbonate)IBA 10/2003

Therapy/Procedure

4	Radiotherapy 12/2021 - 01/2018
3	Lasers (Laser) 12/2010 - 12/2007
2	Chemoradiotherapy 09/2021 - 01/2020
2	Therapeutics 01/2020 - 11/2005
1	Brachytherapy 09/2021
1	Drug Therapy (Chemotherapy) 02/2009
1	Peritoneal Dialysis 10/2003